Nanobots

bloodstream nanobots.

Eric Drexler foresaw this sort of thing three decades ago. It’s just the beginning.

[Update a while later]

Biotech’s potential new cancer cure:

Newly marketed drugs called checkpoint inhibitors are curing a small percentage of skin and lung cancers, once hopeless cases. More than 60,000 people have been treated with these drugs, which are sold by Merck and Bristol-Myers Squibb. The treatments work by removing molecular brakes that normally keep the body’s T cells from seeing cancer as an enemy, and they have helped demonstrate that the immune system is capable of destroying cancer.

Faster, please.

Biting Commentary about Infinity…and Beyond!